Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007
ome per share pursuant ... to the terms of the preferred stock resulting in $3317 of net in... allocable to common stockholders. See Note 1 to the Notes to ... Consolidated Financial Statements in the Annual Report on Form 10-... for calculations of the pro forma net income (loss) per share for ...
Date:2/12/2008
ome per share pursuant
to the terms of the preferred stock, resulting in $3,317 of net income
allocable to common stockholders. See Note 1 to the Notes to
Consolidated Financial Statements in the Annual Report on Form 10-K
for calculations of the pro forma net income (loss) per share for the
periods presented.
'/>"/>SOURCE Genoptix, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 Related medicine news :1.
Genoptix, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 12, 20082.
Genoptix, Inc. Announces Pricing for Initial Public Offering3.
MIB Life Index Reports North American Life Insurance Activity Up 1.4% in December4.
NxStage Medical Reports Fourth Quarter and Full Year 2007 Results5.
Nutrition 21 Reports Fiscal Second Quarter 2008 Financial Results6.
Mesa Labs Reports Higher Quarterly Sales and Earnings7.
Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 20078.
Palatin Technologies, Inc. Reports Fiscal Year 2008 Second Quarter Results; Teleconference and Webcast to be held on February 11, 20089.
LCA-Vision Reports Fourth Quarter and Full-Year 2007 Financial Results10.
Neurobiological Technologies Reports Second Quarter Financial Results11.
Hawkins, Inc. Reports Third Quarter, Nine Months Fiscal 2008 Results